Stem Cell Company Executives, Scientists and Investors Will Gather Feb. 17
in New York City to Discuss Commercialization of Stem Cell Products
PHILADELPHIA, Aug. 12 /PRNewswire/ -- RRY Publications today announced the preliminary lineup of presenters for the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors to focus on the commercialization of stem cell products. The Stem Cell Summit is an intensive one-day event that allows attendees to explore the therapeutic applications of stem cells, the successful path to stem cell product commercialization, and the latest investment opportunities within this marketplace.
The 4th Annual Stem Cell Summit features 35 corporate presenters,
keynote speaker Dr. Arnold Caplan, Ph.D., and a scientific panel
discussion. It will take place on February 17, 2009, at Bridgewaters in the
heart of New York City's historic South Street Seaport.
Confirmed presenting stem cell companies include:
3DM, Inc. Incell Corporation, LLC
Aastrom Biosciences, Inc. MaxCyte, Inc.
Aldagen, Inc. Moraga Biotechnology Corporation
AllCells, LLC Neuronyx, Inc.
Arteriocyte, Inc. Novocell, Inc.
BioE Corp. NuVasive, Inc.
California Stem Cell, Inc. Osiris Therapeutics, Inc.
Cellerix, S.A. Progenitor Cell Therapy, Inc.
Cognate BioServices, Inc. Stemagen
Cytori Therapeutics, Inc. Stemina, Inc.
Gamida Cell Ltd. TiGenix NV
Geron Corp. Tissue Genesis, Inc.
Harvest Technologies Corp. Vet-Stem, Inc.
In addition to the company and product overviews, Robin R. Young, CFA,
the leading medical technologies a
|SOURCE RRY Publications|
Copyright©2008 PR Newswire.
All rights reserved